Enanta Pharmaceuticals, Inc. (ENTA)
USD 4.33
(-8.46%)
USD 4.33
(-8.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 79.2 Million USD | -7.64% |
| 2022 | 83.18 Million USD | -14.31% |
| 2021 | 97.07 Million USD | -20.74% |
| 2020 | 122.47 Million USD | -40.31% |
| 2019 | 205.19 Million USD | -0.69% |
| 2018 | 206.62 Million USD | 100.97% |
| 2017 | 102.81 Million USD | 16.48% |
| 2016 | 88.26 Million USD | -45.13% |
| 2015 | 160.88 Million USD | 236.98% |
| 2014 | 47.74 Million USD | 48.94% |
| 2013 | 32.05 Million USD | -23.15% |
| 2012 | 41.7 Million USD | -0.42% |
| 2011 | 41.88 Million USD | 83.99% |
| 2010 | 22.76 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 17.37 Million USD | 9.36% |
| 2024 Q1 | 17.36 Million USD | -4.94% |
| 2024 Q2 | 16.43 Million USD | -5.35% |
| 2023 FY | 76.83 Million USD | -7.64% |
| 2023 Q3 | 18.24 Million USD | 5.71% |
| 2023 Q2 | 17.25 Million USD | -25.22% |
| 2023 Q1 | 23.07 Million USD | 17.35% |
| 2023 Q4 | 18.26 Million USD | 0.12% |
| 2022 Q2 | 18.71 Million USD | -32.31% |
| 2022 Q4 | 19.66 Million USD | 4.79% |
| 2022 Q3 | 18.76 Million USD | 0.25% |
| 2022 FY | 83.18 Million USD | -14.31% |
| 2022 Q1 | 27.64 Million USD | 17.28% |
| 2021 Q2 | 20.13 Million USD | -36.58% |
| 2021 Q4 | 23.57 Million USD | 9.02% |
| 2021 Q3 | 21.62 Million USD | 7.41% |
| 2021 FY | 97.07 Million USD | -20.74% |
| 2021 Q1 | 31.74 Million USD | 34.33% |
| 2020 Q4 | 23.63 Million USD | 26.69% |
| 2020 Q3 | 18.65 Million USD | -32.46% |
| 2020 Q2 | 27.61 Million USD | -47.46% |
| 2020 Q1 | 52.57 Million USD | 2.45% |
| 2020 FY | 122.47 Million USD | -40.31% |
| 2019 FY | 205.19 Million USD | -0.69% |
| 2019 Q1 | 69.88 Million USD | 3.99% |
| 2019 Q2 | 39.63 Million USD | -43.29% |
| 2019 Q3 | 44.36 Million USD | 11.95% |
| 2019 Q4 | 51.31 Million USD | 15.66% |
| 2018 Q2 | 44.04 Million USD | 15.59% |
| 2018 FY | 206.62 Million USD | 100.97% |
| 2018 Q4 | 67.2 Million USD | 17.36% |
| 2018 Q3 | 57.26 Million USD | 30.0% |
| 2018 Q1 | 38.1 Million USD | -49.81% |
| 2017 FY | 102.81 Million USD | 16.48% |
| 2017 Q4 | 75.92 Million USD | 910.88% |
| 2017 Q3 | 7.51 Million USD | -16.16% |
| 2017 Q2 | 8.95 Million USD | -14.0% |
| 2017 Q1 | 10.41 Million USD | -18.88% |
| 2016 FY | 88.26 Million USD | -45.13% |
| 2016 Q1 | 48.44 Million USD | 236.05% |
| 2016 Q2 | 13 Million USD | -73.16% |
| 2016 Q3 | 13.97 Million USD | 7.49% |
| 2016 Q4 | 12.84 Million USD | -8.13% |
| 2015 Q2 | 57.36 Million USD | -25.98% |
| 2015 Q4 | 14.41 Million USD | 24.29% |
| 2015 Q3 | 11.59 Million USD | -79.78% |
| 2015 Q1 | 77.49 Million USD | 2838.87% |
| 2015 FY | 160.88 Million USD | 236.98% |
| 2014 Q3 | 42.05 Million USD | 1846.81% |
| 2014 Q1 | 893 Thousand USD | -33.8% |
| 2014 FY | 47.74 Million USD | 48.94% |
| 2014 Q4 | 2.63 Million USD | -93.73% |
| 2014 Q2 | 2.16 Million USD | 141.88% |
| 2013 Q1 | 27.85 Million USD | 1399.41% |
| 2013 Q3 | 1.64 Million USD | 37.88% |
| 2013 Q4 | 1.34 Million USD | -18.19% |
| 2013 FY | 32.05 Million USD | -23.15% |
| 2013 Q2 | 1.19 Million USD | -95.71% |
| 2012 Q4 | 1.85 Million USD | -26.91% |
| 2012 Q3 | 2.54 Million USD | -93.05% |
| 2012 Q1 | 741 Thousand USD | 0.0% |
| 2012 FY | 41.7 Million USD | -0.42% |
| 2012 Q2 | 36.56 Million USD | 4834.55% |
| 2011 FY | 41.88 Million USD | 83.99% |
| 2011 Q4 | - USD | 0.0% |
| 2010 FY | 22.76 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -108.295% |
| Alkermes plc | 1.37 Billion USD | 94.238% |
| Agenus Inc. | 139.61 Million USD | 43.27% |
| Aptorum Group Limited | -1.11 Million USD | 7205.486% |
| Ardelyx, Inc. | 106.66 Million USD | 25.742% |
| Dyadic International, Inc. | 922.95 Thousand USD | -8481.548% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -276.07% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 45400.069% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 692.94% |
| Novavax, Inc. | 639.93 Million USD | 87.623% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 269.098% |
| Pyxis Oncology, Inc. | -2 Million USD | 4060.2% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 15427.453% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -315.922% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 179343.233% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 15129.222% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 180.642% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -9775.81% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 96690.244% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 41.447% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -906.276% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 181.696% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 94.782% |
| AlloVir, Inc. | -398 Thousand USD | 20000.503% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 67.099% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -18580.189% |
| Bicycle Therapeutics plc | -129.52 Million USD | 161.152% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -65903.333% |
| ChromaDex Corporation | 50.78 Million USD | -55.975% |
| Chimerix, Inc. | 324 Thousand USD | -24345.679% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 354.122% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 202.07% |
| CRISPR Therapeutics AG | 240.95 Million USD | 67.129% |
| Precision BioSciences, Inc. | 40.47 Million USD | -95.701% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 180.686% |
| Fortress Biotech, Inc. | 57.85 Million USD | -36.906% |
| Fortress Biotech, Inc. | 57.85 Million USD | -36.906% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -377.795% |
| ImmuCell Corporation | 4.39 Million USD | -1701.612% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 174.634% |
| Immix Biopharma, Inc. | -5468.00 USD | 1448600.366% |
| Incyte Corporation | 3.44 Billion USD | 97.698% |
| Innoviva, Inc. | 261.06 Million USD | 69.661% |
| IO Biotech, Inc. | -756 Thousand USD | 10576.72% |
| Jaguar Health, Inc. | 7.72 Million USD | -925.427% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 12028.313% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 33.861% |
| ContextLogic Inc. | 59 Million USD | -34.244% |
| MiMedx Group, Inc. | 266.84 Million USD | 70.318% |
| MEI Pharma, Inc. | 49.32 Million USD | -60.569% |
| NextCure, Inc. | -3.68 Million USD | 2249.946% |
| Onconetix, Inc. | -1.12 Million USD | 7126.833% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 373.419% |
| Opthea Limited | 21.72 Thousand USD | -364559.3% |
| Psyence Biomedical Ltd. | -240.00 USD | 33001766.667% |
| Vaxcyte, Inc. | -75 Million USD | 205.605% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 138264.184% |
| Precigen, Inc. | 106 Thousand USD | -74620.755% |
| Pharming Group N.V. | 220.1 Million USD | 64.015% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -15279.417% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -7749.752% |
| PureTech Health plc | -1.6 Million USD | 5040.986% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 27.847% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 143.661% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 274.747% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 460.231% |
| Acelyrin, Inc. | -115 Thousand USD | 68973.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 788121.092% |
| Summit Therapeutics Inc. | -2.05 Million USD | 3963.61% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 13971.103% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3052.069% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1855.172% |
| Elevation Oncology, Inc. | -39 Thousand USD | 203187.179% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1750.771% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2109.209% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -171.908% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -15868.548% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 144107.273% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 23.915% |
| Seer, Inc. | 7.02 Million USD | -1027.138% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1709.137% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -267.621% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 66943.895% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 55371.073% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -12905.583% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 34.256% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 74.749% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1584180.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -2977.078% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 156197.753% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -169.521% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 34239.655% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 16198.374% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1215.864% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 16790.514% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 761676.923% |
| Soligenix, Inc. | 97.31 Thousand USD | -81292.648% |
| Century Therapeutics, Inc. | -10.8 Million USD | 832.76% |
| Kura Oncology, Inc. | -849 Thousand USD | 9429.093% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 218.032% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 53980.272% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 20.027% |
| Autolus Therapeutics plc | -4.86 Million USD | 1727.368% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -91.379% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 47245.238% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 16.384% |
| GRI Bio, Inc. | 10.84 Million USD | -630.597% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3018.285% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1011.753% |
| IGM Biosciences, Inc. | -211.66 Million USD | 137.42% |
| INmune Bio, Inc. | 155 Thousand USD | -50999.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -27.874% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5358.214% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 12314.282% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 270660.907% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -19602.488% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 4068.136% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 25404.792% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 16.152% |
| Verastem, Inc. | -62 Thousand USD | 127848.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3152.731% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 30446.36% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -2516.584% |
| Histogen Inc. | 3.76 Million USD | -2001.459% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -13646.423% |
| Surrozen, Inc. | -27.23 Million USD | 390.87% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1569.735% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 6673.601% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 408.824% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -294.993% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 4000302.02% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1205.613% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 118084.24% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 48.832% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -54223.731% |
| Apollomics, Inc. | 127 Thousand USD | -62265.354% |
| Amarin Corporation plc | 165.54 Million USD | 52.154% |
| Mesoblast Limited | -9.81 Million USD | 906.969% |
| Turnstone Biologics Corp. | 16.5 Million USD | -379.85% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 171.685% |
| Synaptogenix, Inc. | -6347.00 USD | 1247996.644% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 155401.961% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 50.916% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 95.494% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3002.309% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 170.616% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 76.572% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 694384.712% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1365.24% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 7248.375% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -982.317% |
| Insmed Incorporated | 239.63 Million USD | 66.948% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2113.639% |
| OmniAb, Inc. | 14.66 Million USD | -440.015% |
| Alector, Inc. | -95.05 Million USD | 183.326% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 36.95% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 282.233% |
| Zai Lab Limited | 170.9 Million USD | 53.656% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 3.265% |
| Aura Biosciences, Inc. | -1.29 Million USD | 6216.139% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -60826.154% |
| Immunic, Inc. | -111 Thousand USD | 71454.955% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -399.584% |
| Veracyte, Inc. | 248.14 Million USD | 68.082% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.133% |
| FibroGen, Inc. | 128.9 Million USD | 38.556% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 14043362.411% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 778.879% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.67% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -20260.925% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 77.711% |
| TG Therapeutics, Inc. | 219.1 Million USD | 63.852% |
| Galecto, Inc. | -830 Thousand USD | 9642.651% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 5818.7% |
| Fortrea Holdings Inc. | 424 Million USD | 81.32% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 191.919% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 14068.959% |
| XBiotech Inc. | -1.74 Million USD | 4641.514% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 7248.375% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 270.437% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 204.859% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -7.903% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -371.368% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 79.641% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 259.534% |
| Vaxxinity, Inc. | -2.23 Million USD | 3645.389% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 75.76% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 799.445% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -223.929% |
| NexImmune, Inc. | -1.02 Million USD | 7827.431% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1466640.741% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1214.661% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.299% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 118620.957% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2330.47% |
| Ainos, Inc. | -253.73 Thousand USD | 31315.49% |
| Pluri Inc. | 322 Thousand USD | -24497.516% |
| Prothena Corporation plc | -129.2 Million USD | 161.303% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -57.076% |
| Celularity Inc. | 6.75 Million USD | -1072.524% |
| Rallybio Corporation | -150 Thousand USD | 52902.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 342.905% |
| MeiraGTx Holdings plc | 287 Thousand USD | -27497.213% |
| Omeros Corporation | -69.77 Million USD | 213.507% |
| Humacyte, Inc. | -76.55 Million USD | 203.467% |
| Immunocore Holdings plc | 248.39 Million USD | 68.113% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 622.144% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -26.966% |
| Blueprint Medicines Corporation | 236.58 Million USD | 66.522% |
| CalciMedica, Inc. | -58 Thousand USD | 136658.621% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 5654.278% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -172.6% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 2884.951% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 356.614% |
| Pulmatrix, Inc. | -8.22 Million USD | 1063.552% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 6869.573% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 19950.627% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 119.861% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -2753.597% |
| Cytokinetics, Incorporated | -322.59 Million USD | 124.552% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -9087.28% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 23326.979% |
| Vor Biopharma Inc. | -3.49 Million USD | 2368.156% |
| Roivant Sciences Ltd. | 109.23 Million USD | 27.492% |
| Evogene Ltd. | 1.39 Million USD | -5561.472% |
| ProKidney Corp. | -3.16 Million USD | 2599.337% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 280.37% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1055.082% |
| CorMedix Inc. | -205.56 Thousand USD | 38630.468% |
| BioLineRx Ltd. | 1.1 Million USD | -7048.375% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 200.678% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 240112.121% |
| Atai Life Sciences N.V. | -5000.00 USD | 1584180.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 65096.43% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 82604.167% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 5802.232% |
| Sagimet Biosciences Inc. | 2 Million USD | -3860.2% |
| MediciNova, Inc. | 979.7 Thousand USD | -7984.474% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 193.934% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 83865.004% |
| GeoVax Labs, Inc. | -20.72 Million USD | 482.245% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 67.61% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1985.361% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 90.92% |
| Mereo BioPharma Group plc | 7.42 Million USD | -966.577% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 25649.677% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 660133.333% |
| Absci Corporation | -41.84 Million USD | 289.261% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1584180.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 203.707% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 3318.367% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 62.943% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 8517.003% |
| Allakos Inc. | -6.14 Million USD | 1389.757% |
| Imunon, Inc. | -720 Thousand USD | 11100.479% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 214.795% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 83.357% |
| BioAtla, Inc. | -103.73 Million USD | 176.355% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 694384.712% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 44596.629% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 132.619% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 25567.524% |
| XOMA Corporation | 3.86 Million USD | -1951.386% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 213.011% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -435.379% |
| aTyr Pharma, Inc. | -2.38 Million USD | 3416.75% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -535.666% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 273217.241% |
| Viridian Therapeutics, Inc. | -1 Million USD | 7957.54% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -609261438.462% |
| Akari Therapeutics, Plc | -4000.00 USD | 1980200.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 87.564% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -40578.349% |
| UroGen Pharma Ltd. | 73.35 Million USD | -7.978% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 396.711% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -682104.996% |
| Orgenesis Inc. | -5.72 Million USD | 1483.476% |
| Entera Bio Ltd. | -56 Thousand USD | 141535.714% |
| GH Research PLC | -315 Thousand USD | 25244.127% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 42006.878% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 15186.476% |
| Xencor, Inc. | -85.26 Million USD | 192.897% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 35942.644% |
| Replimune Group, Inc. | -2.65 Million USD | 3083.202% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 8010.622% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 55.464% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -40578.349% |
| Portage Biotech Inc. | -54 Thousand USD | 146774.074% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 83865.004% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 21109.019% |
| OncoCyte Corporation | 413 Thousand USD | -19077.724% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1762146.719% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 35677577.477% |
| Purple Biotech Ltd. | -196 Thousand USD | 40510.204% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -783.185% |
| scPharmaceuticals Inc. | 9.78 Million USD | -709.691% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 858.299% |
| HilleVax, Inc. | -2.15 Million USD | 3773.655% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 81753.608% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 527985.897% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 11956.886% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 344465.217% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1055286.673% |
| Savara Inc. | -44.26 Million USD | 278.944% |
| Curis, Inc. | 9.81 Million USD | -707.298% |
| Daré Bioscience, Inc. | 2.76 Million USD | -2759.844% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 63570.847% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 4680.914% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 34838.596% |
| BeiGene, Ltd. | 2.07 Billion USD | 96.19% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 2932.862% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 119.818% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -39.719% |
| Erasca, Inc. | -3.73 Million USD | 2222.294% |
| bluebird bio, Inc. | -4.03 Million USD | 2065.36% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 280786.087% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 95.841% |
| DBV Technologies S.A. | 15.72 Million USD | -403.586% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 280786.087% |
| Moderna, Inc. | 2.15 Billion USD | 96.325% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 8756.175% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -889.308% |
| Molecular Templates, Inc. | 50.39 Million USD | -57.166% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 14876.866% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 40.799% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1372.967% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 301.317% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 171.273% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2307.469% |
| MacroGenics, Inc. | 50.52 Million USD | -56.756% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1398.852% |
| Prime Medicine, Inc. | -147.9 Million USD | 153.551% |
| Aditxt, Inc. | -111.66 Thousand USD | 71033.19% |
| Adagene Inc. | 18.11 Million USD | -337.314% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -16130.328% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 43.507% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 49.819% |
| SciSparc Ltd. | 2.19 Million USD | -3506.74% |
| Vericel Corporation | 135.57 Million USD | 41.58% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 316296.255% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 255745.213% |
| Generation Bio Co. | -73.91 Million USD | 207.161% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 18224.485% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -45.012% |
| Invivyd, Inc. | -2.02 Million USD | 4005.523% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 126.328% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 76671.473% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 17.811% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 19.416% |
| ADMA Biologics, Inc. | 88.21 Million USD | 10.218% |
| Clene Inc. | 533 Thousand USD | -14760.038% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -228.522% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 8376.28% |
| GeoVax Labs, Inc. | -20.72 Million USD | 482.245% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -3884.105% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 40860.411% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -59.028% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1216.808% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 9574.163% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 5.048% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -108232.421% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -48.986% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 145.733% |
| Trevena, Inc. | 1.45 Million USD | -5343.574% |
| Surrozen, Inc. | -27.23 Million USD | 390.87% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 22537.394% |
| Cingulate Inc. | -582.91 Thousand USD | 13687.503% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 255596.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 502.071% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1046387.979% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 9090.238% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 88.364% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 8116.599% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 140677.189% |
| Kronos Bio, Inc. | 1.37 Million USD | -5672.886% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 247.587% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 27224.658% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 16319.891% |
| ImmunityBio, Inc. | -17.89 Million USD | 542.728% |
| Korro Bio, Inc. | -3.63 Million USD | 2281.928% |
| Kineta, Inc. | 5.43 Million USD | -1357.832% |
| BioVie Inc. | -229.37 Thousand USD | 34630.053% |
| Codexis, Inc. | 57.33 Million USD | -38.145% |
| Celularity Inc. | 6.75 Million USD | -1072.524% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1873.686% |
| Celcuity Inc. | -142.77 Thousand USD | 55575.864% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -156460.585% |
| Cibus, Inc. | 1.42 Million USD | -5469.902% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 21277.54% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 445.582% |
| IN8bio, Inc. | -2.5 Million USD | 3266.893% |
| Kodiak Sciences Inc. | -25.94 Million USD | 405.253% |
| Annexon, Inc. | -3.26 Million USD | 2524.365% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 3974.951% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 289.769% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -12275.625% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 89.826% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 54.205% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 4268.632% |
| Arcellx, Inc. | 108.27 Million USD | 26.852% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 344.691% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 474.452% |
| Moolec Science SA | -143.3 Thousand USD | 55369.53% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 287.164% |
| Geron Corporation | -123.5 Million USD | 164.131% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2309.614% |
| Royalty Pharma plc | 1.79 Billion USD | 95.585% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 213.003% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2192901.772% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -34129.508% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 171.09% |
| Humacyte, Inc. | -76.55 Million USD | 203.467% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 8444.518% |
| 89bio, Inc. | -273 Thousand USD | 29112.454% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 6401.034% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 9440.094% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 64493.496% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -6978.105% |
| Notable Labs, Ltd. | 113 Thousand USD | -69992.035% |
| Liquidia Corporation | 14.6 Million USD | -442.493% |
| Mustang Bio, Inc. | -2.22 Million USD | 3659.73% |
| Immunovant, Inc. | -231 Thousand USD | 34387.446% |
| Quantum-Si incorporated | 488 Thousand USD | -16130.328% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 242.558% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 264113.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -4153.706% |
| Acasti Pharma Inc. | -11 Thousand USD | 720136.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 38808.416% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 12314.282% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 147.283% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -6880.909% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 20888.451% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 4145.148% |
| PepGen Inc. | -1.18 Million USD | 6789.527% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 62465.354% |
| United Therapeutics Corporation | 2.07 Billion USD | 96.174% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 445.914% |
| Solid Biosciences Inc. | -76.56 Million USD | 203.449% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 96008.359% |
| Immuneering Corporation | -764.13 Thousand USD | 10465.143% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -119427.949% |
| Belite Bio, Inc | -399 Thousand USD | 19950.627% |
| XOMA Corporation | 3.86 Million USD | -1951.386% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 495.308% |
| Bionomics Limited | -434.44 Thousand USD | 18330.909% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 7474.674% |
| uniQure N.V. | 2.21 Million USD | -3475.801% |
| Cassava Sciences, Inc. | -89.42 Million USD | 188.572% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 186.027% |
| Forte Biosciences, Inc. | -9000.00 USD | 880144.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 9585.509% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 18224.485% |
| Altimmune, Inc. | -65.37 Million USD | 221.157% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 78.122% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 7474.674% |
| Compugen Ltd. | 31.45 Million USD | -151.801% |
| Peak Bio, Inc. | 367.76 Thousand USD | -21436.345% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -223.071% |
| Benitec Biopharma Inc. | 108 Thousand USD | -73237.037% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 101643.59% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 6683.874% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 4447.091% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 66657.983% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 6683.874% |
| Instil Bio, Inc. | -4.75 Million USD | 1765.349% |
| argenx SE | 1.1 Billion USD | 92.855% |
| Immunome, Inc. | -8.9 Million USD | 989.233% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 4290.688% |
| Verona Pharma plc | -679.62 Thousand USD | 11754.091% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 45359.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 3420.922% |
| CervoMed Inc. | -1.29 Million USD | 6222.63% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 3390.569% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1758.028% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3105.342% |
| Moolec Science SA | -143.3 Thousand USD | 55369.53% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 19511.318% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3064.745% |
| AnaptysBio, Inc. | 14.78 Million USD | -435.85% |
| Design Therapeutics, Inc. | -537 Thousand USD | 14849.348% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 18648.946% |
| NeurAxis, Inc. | 2.15 Million USD | -3572.456% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -3590.774% |
| Lumos Pharma, Inc. | 2 Million USD | -3846.388% |
| Achilles Therapeutics plc | -4.73 Million USD | 1774.055% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 45359.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 75050.556% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -150.18% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -9087.28% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 7774.806% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 273.891% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -184095.349% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 9735.523% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 602045.584% |
| Palisade Bio, Inc. | 246 Thousand USD | -32096.748% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 240112.121% |
| Beam Therapeutics Inc. | -59.67 Million USD | 232.732% |
| Neurogene Inc. | -3.26 Million USD | 2528.081% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 43.156% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2245.287% |
| Sesen Bio, Inc. | 40 Million USD | -98.01% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 26768.013% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2066.806% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 927.974% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -462.528% |
| Athira Pharma, Inc. | -969 Thousand USD | 8273.787% |
| Vaccinex, Inc. | -16 Million USD | 594.901% |
| HCW Biologics Inc. | -574.82 Thousand USD | 13878.826% |
| XOMA Corporation | 3.86 Million USD | -1951.386% |
| Nektar Therapeutics | 53.47 Million USD | -48.106% |
| Arvinas, Inc. | 71.8 Million USD | -10.312% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 194.899% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 226.171% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 24697.516% |
| Rezolute, Inc. | -36 Thousand USD | 220111.111% |
| Clene Inc. | 533 Thousand USD | -14760.038% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 6168635.826% |
| BeyondSpring Inc. | 1.75 Million USD | -4423.358% |
| Synlogic, Inc. | -1.92 Million USD | 4216.632% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 214164.865% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1350.853% |
| Peak Bio, Inc. | 367.76 Thousand USD | -21436.345% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 517.677% |
| Krystal Biotech, Inc. | 47.6 Million USD | -66.377% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 43.863% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1476.199% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3158.992% |
| MannKind Corporation | 136.19 Million USD | 41.843% |
| Ikena Oncology, Inc. | -50.49 Million USD | 256.864% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 27.212% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1906.249% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 31530.159% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1584180.0% |
| Legend Biotech Corporation | 140.92 Million USD | 43.799% |
| Mural Oncology plc | -2.56 Million USD | 3185.469% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 14474.592% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 79304.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -281.632% |
| REGENXBIO Inc. | 53.02 Million USD | -49.36% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1578.527% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 41271.67% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 4672.979% |
| Vaxart, Inc. | -60.76 Million USD | 230.349% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 30240.802% |
| Cellectis S.A. | 18 Thousand USD | -439922.222% |
| Longeveron Inc. | 221 Thousand USD | -35738.914% |
| Repare Therapeutics Inc. | -80.07 Million USD | 198.918% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 92.753% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 6220.866% |
| Revolution Medicines, Inc. | -399.66 Million USD | 119.818% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 226397.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -161540.816% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.08% |
| Denali Therapeutics Inc. | -93.34 Million USD | 184.851% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 316296.255% |
| Veru Inc. | 7.56 Million USD | -946.851% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 52552.98% |
| Cingulate Inc. | -582.91 Thousand USD | 13687.503% |
| Passage Bio, Inc. | -3.72 Million USD | 2228.568% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 657722.052% |
| Exicure, Inc. | -1.42 Million USD | 5665.987% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 20779.896% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -2830.226% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 15549.164% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -16.261% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 53041.373% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 233.777% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -20156.777% |
| OmniAb, Inc. | 14.66 Million USD | -440.015% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -296.159% |
| Lipocine Inc. | -2.85 Million USD | 2878.29% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 4397.558% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1488.326% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5358.214% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -5.162% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 121952.308% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 6.041% |
| Ocugen, Inc. | -33.53 Million USD | 336.169% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 2604.87% |
| Q32 Bio Inc. | 578 Thousand USD | -13603.114% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 29988.302% |
| Alumis Inc. Common Stock | -1.28 Million USD | 6268.536% |
| Equillium, Inc. | 35.95 Million USD | -120.268% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 4739.953% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -15719.317% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1916016.788% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 30680.695% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -18637.107% |
| Dominari Holdings Inc. | 2.03 Million USD | -3784.453% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 43269.765% |
| vTv Therapeutics Inc. | -13.59 Million USD | 682.597% |
| Bio-Techne Corporation | 773.07 Million USD | 89.755% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -357.324% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 82.811% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 6875.364% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 430.292% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -577.131% |
| Nkarta, Inc. | -5.86 Million USD | 1449.531% |
| BioCardia, Inc. | -7.24 Million USD | 1192.62% |
| Iterum Therapeutics plc | -1.75 Million USD | 4625.943% |